The findings reinforce vaccination as a protective tool for children with chronic allergic conditions, indicating safety and added benefits for this vulnerable group.

Vaccinated children showed notably lower incidence of infections such as otitis media, pneumonia, bronchitis, bronchiolitis, sinusitis, upper respiratory infections, and skin infections like impetigo and molluscum contagiosum.

The study was presented at the 2025 ACAAI Annual Scientific Meeting in Orlando and published in the Annals of Allergy, Asthma & Immunology.

There were no significant differences observed in psychiatric or growth-related outcomes between vaccinated and unvaccinated children.

The article places the findings within ACAAI communications and provides sources for further information on atopic dermatitis and vaccines.

Time-to-event analyses indicated delayed onset for several conditions after vaccination, including allergic rhinitis, viral infections, and ear infections.

A new study suggests that COVID-19 vaccination is associated with fewer infections and allergic conditions in children with atopic dermatitis compared with unvaccinated peers.

The study reports risk reductions for several conditions (e.g., lower risk of otitis media and pneumonia) and notes hazard analyses showing delayed onset with p-values under 0.05.

Hazard analyses showed delayed onset of multiple conditions—such as otitis media, bronchiolitis, viral infections, upper respiratory infections, and allergic rhinitis—with all p-values below 0.05.